Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: May 27, 2026

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

The revised stage classification system for primary lung cancer.

Daniel J Boffa1

  • 1Thoracic Surgery, Yale University School of Medicine, 330 Cedar Street, BB205, 208062, New Haven, CT 06520, USA. daniel.boffa@yale.edu

Clinics in Chest Medicine
|November 8, 2011
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-World Outcomes of Radiation After Chemoimmunotherapy for Stage III Lung Cancer.

Clinical lung cancer·2026
Same author

Updated Review: Using the National Cancer Database for Outcomes-Based Research.

Journal of the American College of Surgeons·2026
Same author

Use of Complementary and Alternative Medicine in the Management of Breast Cancer.

JAMA network open·2026
Same author

Surgical Trainee Familiarity and Knowledge of the Commission on Cancer Operative Standards: A National Survey Study.

Journal of the American College of Surgeons·2026
Same author

Adenocarcinoma of the esophagus and gastroesophageal junction: The evolving treatment landscape for locally advanced and metastatic disease in the era of immune checkpoint inhibitors and biomarker-driven therapeutics.

CA: a cancer journal for clinicians·2026
Same author

Real-world perioperative outcomes of neoadjuvant chemoimmunotherapy in non-small cell lung cancer.

JTCVS open·2025

The updated cancer stage classification system aids prognosis but may confuse treatment recommendations. International collaboration improved this global staging effort.

Area of Science:

  • Oncology
  • Clinical Staging

Background:

  • The previous cancer staging systems had limitations in accurately predicting patient prognosis.
  • Accurate staging is crucial for effective treatment planning and clinical decision-making.

Purpose of the Study:

  • To evaluate the impact of a revised cancer stage classification system on prognostic accuracy.
  • To assess the clarity and utility of stage-specific treatment recommendations within the new system.

Main Methods:

  • Analysis of data related to the revised cancer stage classification system.
  • Review of clinical outcomes and prognostic estimations based on the new staging.
  • Assessment of the integration of treatment recommendations with staging.

Main Results:

Related Experiment Videos

Last Updated: May 27, 2026

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model
07:13

Comparison of Predictive Performance of Three Lymph Node Staging Systems in Colorectal Signet Ring Cell Carcinoma Based on Machine Learning Model

Published on: April 18, 2025

  • The revised stage classification system has enhanced clinicians' ability to estimate prognosis.
  • The emphasis on stage-specific treatment recommendations may introduce confusion.
  • International collaboration was key to the development of this global staging system.

Conclusions:

  • The revised staging system offers improved prognostic accuracy.
  • Clinicians should integrate prognostic information with other factors and randomized trial data for treatment planning.
  • Further revisions are anticipated to address remaining questions and refine the system.